Form D · Biotechnology
Ocuphire Pharma, Inc.
Farmington H Ills, MI · CIK 0001738266
Offering snapshot reported Feb 3, 2020 · SEC filing
- Reported sold
- $2.13M Offering amount: $2.13M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 21, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 3, 2020 | Initial | $2,126,253 | No comparison | 4 | SEC filing |
| Feb 6, 2019 | Amendment | $1,774,460 | $1,040,000vs Jun 5, 2018 | 21 | SEC filing |
| Jun 5, 2018 | Initial | $734,460 | No comparison | 8 | SEC filing |
| Apr 24, 2018 | Initial | $17,000 | No comparison | 72 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-359570
Source: Form D, filed Feb 3, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sean Ainsworth | Director |
| Meyer Alan | Director |
| Cam Gallagher | Director |
| Bernhard Hoffmann | Executive |
| James Manuso | Director |
| Alan Meyer | Director |
| Mina Sooch | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
37000 Grand River Ave Suite 120
Farmington H Ills, MI, 48335
Farmington H Ills, MI, 48335